No profile icon.   Welcome, Guest [ Sign In ]

Institutional Biosafety Committee (IBC)

In accordance with the National Institutes of Health (NIH) Guidelines, the National Cancer Institute-Frederick (NCI-F) has established an Institutional Biosafety Committee (IBC) . The committee represents the interests of the surrounding community with respect to public health and protection of the environment, animal containment principles and biological safety.

The IBC is responsible for reviewing projects that involve, but are not limited to: rDNA/RNA; RNAi (shRNA/siRNA); Pathogens; Oncogenes; Biological Toxins; Human Materials; Other potentially infectious material (OPIM); Transgenic or Knock-Out/In Animals; Synthetic Biology; Nanotechnology; and Dual Use Materials.

Important Note:

To ensure adequate and timely review, the IBC has implemented registration submission deadlines (see right).

There will be no exceptions to this requirement.

2015 Meeting Dates

  • December 16, 2014
  • January 20
  • February 17
  • March 17
  • April 21
  • May 19
  • June 16
  • July 21
  • August 18
  • September 15
  • October 20
  • November 17
  • December 15

2015 Submission Deadlines

  • November 19, 2014
  • December 16, 2014
  • January 20
  • February 17
  • March 17
  • April 21
  • May 19
  • June 16
  • July 21
  • August 18
  • September 15
  • October 20
  • November 17

All meetings will be held in Building 549 Executive Board Room from 12:00 to 3:00.

Current Topics in Biosafety

New! Synthetic Nucleic Acid Molecules – changes to NIH Guidelines

Investigator Responsibilities under NIH Guidelines

NIH Dual Use Research

Biosecurity News in Brief

Strain database: To determine if a particular mouse strain is registered with the NCI-Frederick IBC, please contact NCI-Frederick IBC, 301-846-1451.